Application YC di Matrubials

Summer 2021Active

Matrubials ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 4
Stato: Active
Lanciata: 2021

Founder

Bruce GermanFounder
Carlito LebrillaFounder
David MillsFounder

Cosa fa Matrubials

Matrubials is an anti-infectives company, focused on human milk peptides as therapeutics to address antimicrobial resistance and modern diseases. Currently the global rise in severe bacterial infections and the drying pipeline of effective treatments are burdensome for healthcare and economics. Sculpted by evolution, milk, first food for the newborn, provides an exemplary solution to address the nutritive and protective challenges an infant is faced with. The anti-pathogenic molecules from milk can be developed into therapeutics geared towards all-age diseases. Our first indication is bacterial vaginosis, a bacterial dysbiosis related inflammation that results in recurrent infections, disruption of homeostasis and long-term clinical complications in women of reproductive age, including but not limited to preterm births, fertility issues and increased rates of STDs. Our next inflection point is the evaluation of rapidly acting and selective candidate peptides in pre-clinical host impact and early safety studies, which can aid clinical and portfolio development towards topical applications.

Application YC di Matrubials, ricostruita

Domanda per Y Combinator

Matrubials, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Matrubials

Describe what your company does in 50 characters or less.

Milk-inspired therapeutics for infectious diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing antimicrobial peptides derived from human milk to treat bacterial infections. Our lead program targets bacterial vaginosis, aiming to restore microbial balance and prevent recurrent infections and inflammation that affect women's reproductive health. These peptides act selectively to avoid disrupting beneficial bacteria and offer a novel treatment approach against antimicrobial resistance.

Where do you live now, and where would the company be based after YC?

We live and work in Davis, CA. After YC, the company will remain based here to leverage local research connections and our core scientific team.

Explain your decision regarding location.

Davis hosts our founders and is near key research institutions. Staying here maintains continuity in science and development and supports our focused approach on milk-based therapeutics.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Matrubials?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Matrubials (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Matrubials si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Matrubials?

Matrubials apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato Matrubials?

Matrubials è stato fondato da Bruce German, Carlito Lebrilla, David Mills.

Cosa fa Matrubials?

Developing milk-inspired therapeutics for infectious diseases

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Matrubials, e di ogni altro batch YC, è in YC Insights.